[Incidence and significance of therapy-associated late toxicity in Hodgkin's disease].
Streit
M
M
Abteilung Innere Medizin mit Schwerpunkt Hämatologie und Onkologie, Klinikum Benjamin Franklin, Freien Universität Berlin.
Thiel
E
E
Kreuser
E D
ED
D000293:Adolescent; D000328:Adult; D000970:Antineoplastic Agents / Q000009:adverse effects*; D002648:Child; D005260:Female; D005767:Gastrointestinal Diseases / Q000139:chemically induced / Q000209:etiology; D006331:Heart Diseases / Q000139:chemically induced / Q000209:etiology; D006689:Hodgkin Disease / Q000150:complications* / Q000401:mortality / Q000628:therapy*; D006801:Humans; D007247:Infertility, Female / Q000139:chemically induced / Q000209:etiology; D007248:Infertility, Male / Q000139:chemically induced / Q000209:etiology; D008171:Lung Diseases / Q000139:chemically induced / Q000209:etiology; D008297:Male; D016609:Neoplasms, Second Primary / Q000139:chemically induced / Q000209:etiology*; D011788:Quality of Life; D011878:Radiotherapy / Q000009:adverse effects*; D012307:Risk Factors; D013959:Thyroid Diseases / Q000139:chemically induced / Q000209:etiology
D000970:Antineoplastic Agents
Inzidenz und Signifikanz therapie-assoziierter Spättoxizität bei Morbus Hodgkin.